Navigation Links
Aspirin Reduces Asthma Risk Among Older Women
Date:3/13/2008

Study found 10 percent fewer new cases over a decade

THURSDAY, March 13 (HealthDay News) -- Taking a small dose of aspirin every other day seems to reduce the risk of developing asthma among older women.

The study, appearing in the online issue of Thorax, essentially mirrors a similar study in which men taking aspirin saw the same reduced risk.

But the study authors warned that the research was still not enough to recommend taking aspirin regularly.

"These two studies are not sufficiently strong to make a recommendation for primary prevention of adult-onset asthma," said Dr. Tobias Kurth, who was involved in both studies.

For the many older adults already taken aspirin for its salutary effects on heart health, "this could be an added benefit," he added.

The incidence of asthma is on the increase, possibly due to obesity, dietary factors, exposure to antigens and environmental factors. But the trend also coincides with a decreased use of aspirin as people have switched to other over-the-counter pain relievers, or have avoided aspirin use in children due to concerns about Reyes syndrome.

That led some researchers to wonder whether the reduction in aspirin use was contributing to the rise of asthma.

This study, the first randomized trial in women, looked at almost 40,000 healthy, female health-care professionals aged 45 and over who were participating in the Women's Health Study.

Women were randomized to receive 100 milligrams of aspirin every other day or a placebo. This dose was much lower than that taken by men in the previous study (325 milligrams).

Over the next decade, there were 10 percent fewer new cases of asthma in the women who had been taking aspirin regularly, with one exception: aspirin had no effect in women who were obese.

"It could be due to the low dose, or there may be a biological reason," said Kurth, an associate epidemiologist at Brigham and Womens Hospital and assistant professor of medicine at Harvard Medical School, both in Boston.

"It may be a dose-related issue," added Dr. Len Horovitz, a pulmonary specialist with Lenox Hill Hospital in New York City. "It's basically like a baby aspirin."

The effect in non-obese women was smaller than that seen in men (they saw a 22 percent risk reduction), but that may be at least partly attributable to the lower dose.

Interestingly, aspirin can exacerbate symptoms in 4 percent to 11 percent of people who have already been diagnosed with the condition.

"It's not usual for us to encourage people to take aspirin, because you don't know who does or does not have [this sensitivity] until you have a problem," Horovitz said.

At this point, it's not clear exactly why aspirin has this effect.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on asthma in women.



SOURCES: Tobias Kurth, M.D., Sc.D., associate epidemiologist, Brigham and Women's Hospital, and assistant professor, medicine, Harvard Medical School, Boston; Len Horovitz, M.D., pulmonary specialist, Lenox Hill Hospital, New York City; March 13, 2008, Thorax


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Ibuprofen destroys aspirins positive effect on stroke risk
2. Corgenix to Exhibit AspirinWorks(R) Test at 2008 ACOFP Meeting in Denver
3. Drugs like aspirin could reduce breast cancer and help existing sufferers
4. Women are treated less frequently than men with statins, aspirin and beta-blockers
5. Many stroke, heart attack patients may not benefit from aspirin
6. Regular, long-term aspirin use reduces risk of colorectal cancer
7. Aspirin Resistance Boosts Heart Risks in Cardiac Patients
8. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
9. New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen
10. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
11. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirin Reduces Asthma Risk Among Older Women
(Date:3/24/2017)... ... , ... Texas Physical Therapy Specialists (TexPTS) is pleased to announce the ... clinic is the group’s 7th location in San Antonio and 23rd in Texas. ... care from the clinic, which opened March 22, 2017. , The team ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... financial planning, and related services to families and business owners across eastern Michigan, ... at feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH Food ...
(Date:3/24/2017)... Diego, Calif. (PRWEB) , ... March 24, 2017 ... ... has raised over $100,000 for its innovative EcoQube Frame vertical micro-veggies garden on ... the instant demand for the product – with nearly 2,000 consumers (and counting) ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Assili, announce that they are now offering treatments for sleep apnea and TMJ ... dental offices. Sleep apnea , specifically the obstructive type, is increasingly being ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of ... N.Y., is pleased to announce Westchester resident Lauren C. Enea has joined the firm ... the firm, will concentrate her practice in elder law, Medicaid planning and applications, and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017 Today Stock-Callers.com have issued research ... Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences ... SSH ). These companies are part of the Healthcare sector, ... March 23 rd , 2017, with the NYSE Health Care ... care companies in the S&P 500 were down about 0.4% ...
(Date:3/24/2017)... INDIANAPOLIS , March 24, 2017  Eli ... today announced plans to invest $850 million in ... span facilities across its U.S. enterprise, including research ... The investments are being driven by demand for ... of potential medicines in development targeting cancer, pain, ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
Breaking Medicine Technology: